These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21553347)

  • 1. Activated immune cells in Parkinson's disease.
    Cao JJ; Li KS; Shen YQ
    J Neuroimmune Pharmacol; 2011 Sep; 6(3):323-9. PubMed ID: 21553347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity, dendritic cells and relevance for Parkinson's disease.
    Koutsilieri E; Lutz MB; Scheller C
    J Neural Transm (Vienna); 2013 Jan; 120(1):75-81. PubMed ID: 22699458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.
    Reynolds AD; Stone DK; Mosley RL; Gendelman HE
    J Immunol; 2009 Apr; 182(7):4137-49. PubMed ID: 19299711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of innate and adaptive immunity in Parkinson's disease.
    Kannarkat GT; Boss JM; Tansey MG
    J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune system responses in Parkinson's disease: Early and dynamic.
    Tansey MG; Romero-Ramos M
    Eur J Neurosci; 2019 Feb; 49(3):364-383. PubMed ID: 30474172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate inflammation in Parkinson's disease.
    Perry VH
    Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009373. PubMed ID: 22951445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia and Parkinson's disease: footprints to pathology.
    Lazdon E; Stolero N; Frenkel D
    J Neural Transm (Vienna); 2020 Feb; 127(2):149-158. PubMed ID: 32016606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and adaptive immunity in Parkinson's disease.
    Mosley RL; Hutter-Saunders JA; Stone DK; Gendelman HE
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a009381. PubMed ID: 22315722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson's disease.
    Panaro MA; Cianciulli A
    Curr Pharm Des; 2012; 18(2):200-8. PubMed ID: 22229581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases.
    Huang B; Zhenxin Y; Chen S; Tan Z; Zong Z; Zhang H; Xiong X
    Oxid Med Cell Longev; 2022; 2022():1315248. PubMed ID: 36211819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel SH; Beers DR; Henkel JS
    Trends Immunol; 2010 Jan; 31(1):7-17. PubMed ID: 19879804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADPH oxidase-derived H
    Hou L; Zhou X; Zhang C; Wang K; Liu X; Che Y; Sun F; Li H; Wang Q; Zhang D; Hong JS
    Redox Biol; 2017 Aug; 12():162-170. PubMed ID: 28237879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.
    Lee H; James WS; Cowley SA
    Biochem Soc Trans; 2017 Feb; 45(1):131-139. PubMed ID: 28202666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inflammatory review of Parkinson's disease.
    Orr CF; Rowe DB; Halliday GM
    Prog Neurobiol; 2002 Dec; 68(5):325-40. PubMed ID: 12531233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and peripheral T cell subsets in Parkinson's disease patients with constipation.
    Chen Y; Yu M; Liu X; Qu H; Chen Q; Qian W; Wei D; Xu W; Ma B; Wu W
    Int J Clin Exp Pathol; 2015; 8(3):2495-504. PubMed ID: 26045755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.